NATCAN is updating how we communicate across our programmes and will be shifting activity away from X. This change will help ensure our updates, publications and announcements are shared in the most consistent and accessible way for our audiences.
Over the coming weeks, NATCAN and the audit programme accounts will gradually wind down posting on X. While the accounts will remain visible for reference, they will no longer be actively updated. Each account will carry a clear notice directing followers to our established channels on LinkedIn and Bluesky.
These platforms will continue to be our primary homes for sharing announcements, news and resources across the national cancer audits.
We appreciate the ongoing engagement from clinicians, patients, partners and stakeholders, and look forward to continuing these conversations on our other platforms.
Where to NATCAN:
Where to follow the audits:
| Audit | Bluesky | |
| National Non-Hodgkin Lymphoma Audit | @nnhla-natcan.bsky.social | NNHLA |
| National Lung Cancer Audit | @nlca-natcan.bsky.social | NLCA |
| National Bowel Cancer Audit | @nboca-natcan.bsky.social | NBOCA |
| National Oesophago-Gastric Cancer Audit | @nogca-natcan.bsky.social | NOGCA |
| National Audit of Metastatic Breast Cancer | @naome-natcan.bsky.social | NAoMe |
| National Audit of Primary Breast Cancer | @naopri-natcan.bsky.social | NAoPri |
| National Kidney Cancer Audit | @nkca-natcan.bsky.social | NKCA |
| National Prostate Cancer Audit | @npca-natcan.bsky.social | NPCA |
| National Ovarian Cancer Audit | @noca-natcan.bsky.social | NOCA |
| National Pancreatic Cancer Audit | @npaca-natcan.bsky.social | NPaCA |
This decision reflects the RCS England’s departure from X in January this year. Further details are available in the full statement on the RCS’ website.
Please do not hesitate to contact us with any queries.